Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male.

O'Brien DP, Gale KM, Anderson JS, McVey JH, Miller GJ, Meade TW, Tuddenham EG.

Blood. 1991 Jul 1;78(1):132-40.

3.
4.

Characterization of mild coagulation factor VII deficiency: activity and clearance of the Arg315Trp and Arg315Lys variants in the Cys310-Cys329 loop (c170s).

Furlan Freguia C, Toso R, Pollak ES, Arruda VR, Pinotti M, Bernardi F.

Haematologica. 2004 Dec;89(12):1504-9.

5.

Characterization of a factor VII molecule carrying a mutation in the second epidermal growth factor-like domain.

Kavlie A, Orning L, Grindflek A, Stormorken H, Prydz H.

Thromb Haemost. 1998 Jun;79(6):1136-43.

PMID:
9657438
6.

Characterization of porcine factor VII, X and comparison with human factor VII, X.

Chen Y, Qiao J, Tan W, Lu Y, Qin S, Zhang J, Li S, Bu H, Cheng J.

Blood Cells Mol Dis. 2009 Jul-Aug;43(1):111-8. doi: 10.1016/j.bcmd.2009.02.004. Epub 2009 Mar 16.

PMID:
19286401
7.

Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factor.

Chaing S, Clarke B, Sridhara S, Chu K, Friedman P, VanDusen W, Roberts HR, Blajchman M, Monroe DM, High KA.

Blood. 1994 Jun 15;83(12):3524-35.

8.

Interspecies exchange mutagenesis of the first epidermal growth factor-like domain of human factor VII.

Williamson V, Pyke A, Sridhara S, Kelley RF, Blajchman MA, Clarke BJ.

J Thromb Haemost. 2005 Jun;3(6):1250-6. Epub 2005 May 9.

9.
11.

Factor VII deficiency caused by a structural variant N57D of the first epidermal growth factor domain.

Leonard BJ, Chen Q, Blajchman MA, Ofosu FA, Sridhara S, Yang D, Clarke BJ.

Blood. 1998 Jan 1;91(1):142-8.

12.

Factor VII binding to tissue factor in plasma from warfarin-treated individuals.

Takamiya O, Yoshioka A.

Thromb Res. 1996 Mar 15;81(6):657-63.

PMID:
8868516
13.
14.

Factor VII R110C: a novel missense mutation (Arg110Cys) in the second epidermal growth factor-like domain causing factor VII deficiency in members of a Japanese family.

Suto M, Uchiumi H, Tsukamoto N, Nojima Y, Tamura J, Naruse T.

Blood Coagul Fibrinolysis. 2000 Jul;11(5):415-9.

PMID:
10937801
15.

Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII-R79Q).

O'Brien DP, Kemball-Cook G, Hutchinson AM, Martin DM, Johnson DJ, Byfield PG, Takamiya O, Tuddenham EG, McVey JH.

Biochemistry. 1994 Nov 29;33(47):14162-9.

PMID:
7947828
16.

Molecular characterisation and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency.

Peyvandi F, Jenkins PV, Mannucci PM, Billio A, Zeinali S, Perkins SJ, Perry DJ.

Thromb Haemost. 2000 Aug;84(2):250-7.

PMID:
10959697
17.

The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII.

Kao YH, Lee GF, Wang Y, Starovasnik MA, Kelley RF, Spellman MW, Lerner L.

Biochemistry. 1999 Jun 1;38(22):7097-110.

PMID:
10353820
18.

Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII-tissue factor interaction.

Wildgoose P, Foster D, SchiĆødt J, Wiberg FC, Birktoft JJ, Petersen LC.

Biochemistry. 1993 Jan 12;32(1):114-9.

PMID:
8418832
20.

Supplemental Content

Support Center